vimarsana.com

Page 56 - மருந்து ஒழுங்குமுறை அதிகாரம் ஆஃப் பாக்கிஸ்தான் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SAMAA - DRAP approves Sinopharm vaccine for people above 60

DRAP approves Sinopharm vaccine for people above 60 Vaccintation drive for older people to start from March 15 SAMAA | Health - Posted: Mar 6, 2021 | Last Updated: 1 month ago SAMAA | Health Posted: Mar 6, 2021 | Last Updated: 1 month ago A health worker receives the Sinopharm vaccine at Mayo hospital, Lahore. Photo: Online Listen to the story The Drug Regulatory Authority of Pakistan approved on Friday the Chinese-made Sinopharm vaccine for people above 60 years. The approval comes almost two months after the vaccine was approved for emergency use in the country. Health workers who fall in that age group and are registered with the National Immunisation Management System can now receive the vaccine. Those who haven’t registered themselves can do so on https://nims.nadra.gov.pk/nims/.

Pakistan govt not planning to buy COVID-19 vaccines: Official

Pak govt not planning to buy COVID-19 vaccines; to rely on herd immunity & donated jabs: Officials

Story highlights Herd immunity occurs when a large number of people, usually 70 to 90 per cent, become immune to a contagious disease after being infected to it Pakistan is not planning to buy vaccines anytime soon as it aims to tackle the COVID-19 challenge through herd immunity and donated vaccines from friendly countries like China, authorities have said. So far, four vaccines: Sinophram (China), Oxford-AstraZeneca (UK), Sputnik-V (Russia) and Cansino Bio (China) have been registered in the country. National Health Service (NHS) Secretary Amir Ashraf Khawaja while briefing the Public Accounts Committee on Thursday said that the Pakistan government has no plan to buy vaccines anytime soon and aims to tackle the COVID-19 health challenge through herd immunity and donated vaccines, Dawn newspaper reported.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.